搜索临床试验以:CDX-301
总计6440个结果
-
Beijing GoBroad Hospital招聘中
-
Compass Therapeutics招聘中
-
Brigham and Women's HospitalNational Institutes of Health (NIH); National Institute on Aging (NIA)招聘中
-
EmitBio Inc.NAMSA主动,不招人
-
Bristol-Myers Squibb完全的
-
University Hospital HeidelbergAmsterdam Institute for Global Health and Development; Swiss Tropical & Public Health Institute 和其他合作者招聘中
-
Toshihiko DoiMerck Sharp & Dohme LLC; Oncolys BioPharma Inc完全的
-
Xuanwu Hospital, BeijingBaoding Children's Hospital招聘中
-
Aevi Genomic Medicine, LLC, a Cerecor company完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)主动,不招人
-
Idience Co., Ltd.National OncoVenture; IlDong Pharmaceutical Co Ltd完全的
-
Immunophotonics, Inc.招聘中
-
Hoth Therapeutics, Inc.Worldwide Clinical Trials招聘中
-
Kodiak Sciences Inc终止非增殖性糖尿病视网膜病变美国, 拉脱维亚, 斯洛伐克, 波兰, 波多黎各, 西班牙, 捷克语
-
University of Maryland, BaltimoreBill and Melinda Gates Foundation; Auro Vaccines LLC完全的
-
M.D. Anderson Cancer Center招聘中既往骨髓增生异常综合征引起的急性髓性白血病 | 继发性急性髓性白血病 | 复发性急性髓性白血病 | 难治性急性髓性白血病美国
-
Jonsson Comprehensive Cancer CenterUniversity of California, Los Angeles; Pfizer; Jazz Pharmaceuticals终止
-
ViGenCell Inc.尚未招聘